Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mevo Health vs NP2GO

Mevo Health
Graded #327

Lower grade

vs+20
NP2GO
Graded #37

Higher grade

The verdict

NP2GO takes it — 80.2/100 to 60.2/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +25
56
81
Dose & formulationMevo Health +3
83
80
Clinical oversightNP2GO +12
67
79
Labs & monitoringNP2GO +26
52
78
FulfillmentNP2GO +25
57
82
Contract termsNP2GO +62
20
82
Mevo Health · left barNP2GO · right bar

The numbers

MetricMevo HealthNP2GO
WeighScore60.2/10080.2/100
GradeCB−
Scorecard rank#327#37
Semaglutide$199/mo (all doses, compounded)$150/mo
Tirzepatide$259/mo (all doses, compounded)$250/mo
CoverageCoverage not published40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Mevo Health

Graded #327 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard